References
- Kantor R , KatzensteinDA, EfronB et al. Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration. PLoS Med. 2(4) , e112 (2005).
- Rhee SY , GonzalesMJ, KantorR, BettsBJ, RavelaJ, ShaferRW. Human immunodeficiency virus reverse transcriptaseand protease sequence database. Nucleic Acids Res.31(1) , 298–303 (2003).
- Johnson VA , CalvezV, GünthardHF et al. 2011 Update of the drug resistance mutations in HIV-1. HIV Med. 18 , 156–163 (2010).
- Chan PA , KantorR. Transmitted drug resistance in nonsubtype B HIV-1 infection. HIV Therapy3(5) , 447–465 (2009).
- Frahm N , GoulderPJR, BranderC. Total assessment of HIV-specific CTL responses: epitope clustering, processing preferences, and the impact of HIV sequence heterogeneity. In: HIV Molecular Immunology 2002. Korber BT, Brander C, Haynes BF et al. (Eds). Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, NM, USA 3–22 (2002).
- Grossman Z , PaxinosEE, AverbuchD et al. Mutation D30N is not preferentially selected by human immunodeficiency virus type 1 subtype C in the development of resistance to nelfinavir. Antimicrob. Agents Chemother. 48(6) , 2159–2165 (2004).
- Myers RE , GaleCV, HarrisonA, TakeuchiY, KellamP. A statistical model for HIV-1 sequence classification using the subtype analyser (STAR). Bioinformatics21(17) , 3535–3540 (2005).
- Brenner BG , OliveiraM, Doualla-BellF et al. HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture. AIDS 20(9) , F9–F13 (2006).
- Calazans A , BrindeiroR, BrindeiroP et al. Low accumulation of L90M in protease from subtype F HIV-1 with resistance to protease inhibitors is caused by the L89M polymorphism. J. Infect. Dis. 191 , 1961–1970 (2005).
- Taylor BS , SobieszczykME, McCutchanFE, HammerSM. The challenge of HIV-1 subtype diversity. N. Engl. J. Med.358(15) , 1590–1602 (2008).
- Ou CY , WenigerBG, LuoCC et al. Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand. Lancet 341(8854) , 1171–1174 (1993).
- Abebe A , LukashovVV, Rinke de Wit TF et al. Timing of the introduction into Ethiopia of subcluster C´ of HIV type 1 subtype C. AIDS Res. Hum. Retroviruses17(7) , 657–661 (2001).
- Abebe A , PollakisG, FontanetAL et al. Identification of a genetic subcluster of HIV type 1 subtype C (C´) widespread in Ethiopia. AIDS Res. Hum. Retroviruses 16(17) , 1909–1914 (2000).
- Ou C , TakebeY, LuoC et al. Wide distribution of two subtypes of HIV-1 in Thailand. AIDS Res. Hum. Retroviruses 8(8) , 1471–1472 (1992).
- Kuiken CL , GoudsmitJ. Silent mutation pattern in V3 sequences distinguishes virus according to risk group in Europe. AIDS Res. Hum. Retroviruses10(3) , 319–320 (1994).
- Adwan G , PapaA, KouidouS et al. HIV type 1 sequences with GGC substitution in injecting drug users in Greece. AIDS Res. Hum. Retroviruses 15(7) , 679–680 (1999).
- Shankarappa R , ChatterjeeR, LearnGH et al. Human immunodeficiency virus type 1 env sequences from Calcutta in eastern India: identification of features that distinguish subtype C sequences in India from other subtype C sequences. J. Virol. 75(21) , 10479–10487 (2001).
- Seth P . Evolution of HIV-1 in India. Indian J. Virol.1–5 (2010).
- Kalpana A , SrikanthT, AbhayJ, SushamaJ, SwaraliK, RameshP. gp120 sequences from HIV type 1 subtype C early seroconverters in India. AIDS Res. Hum. Retroviruses20(8) , 889–894 (2004).
- Kalish ML , BaldwinA, RakthamS et al. The evolving molecular epidemiology of HIV-1 envelope subtypes in injecting drug users in Bangkok, Thailand: implications for HIV vaccine trials. AIDS 9(8) , 851 (1995).
- Subbarao S , LimpakarnjanaratK, MastroTD et al. HIV type 1 in Thailand, 1994–1995: persistence of two subtypes with low genetic diversity. AIDS Res. Hum. Retroviruses 14(4) , 319–327 (1998).
- Soares MA , de Oliveira T, Brindeiro RM et al. A specific subtype C of human immunodeficiency virus type 1 circulates in Brazil. AIDS17(1) , 11 (2003).
- Ojesina AI , KankiPJ. HIV-1 subtype and reverse transcriptase genotype: role for geographical location and founder effects. PLoS Med.3(12) , e540 (2006).
- Neogi U , SahooPN, KumarR, De Costa A, Shet A. Characterization of HIV type 1 subtype C protease gene: selection of L63P mutation in protease inhibitor-naive indian patients. AIDS Res. Hum. Retroviruses27(11) , 1249–1253 (2011).
- Neogi U , PrarthanaBS, GuptaS et al. Naturally occurring polymorphisms and primary drug resistance profile among antiretroviral-naive individuals in Bangalore, India. AIDS Res. Hum. Retroviruses 26(10) , 1097–1101 (2010).
- Bello G , PassaesCP., Guimarães ML et al. Origin and evolutionary history of HIV-1 subtype C in Brazil. AIDS22(15) , 1993 (2008).
- De Oliveira T , PillayD, GiffordRJ. The HIV-1 subtype C epidemic in South America is linked to the United Kingdom. PloS One5(2) , e9311 (2010).
- Morgado MG , SabinoEC, ShpaerEG et al. V3 region polymorphisms in HIV-1 from Brazil: prevalence of subtype B strains divergent from North American/European prototype and detection of subtype F. AIDS Res. Hum. Retroviruses 10(5) , 569–576 (1994).
- Ana V , KokoO. Close phylogenetic relationship between Angolan and Romanian HIV-1 subtype F1 isolates. Reterovirology6 , 39 (2009).
- Paraskevis D , PybusO, MagiorkinisG et al. Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach. Retrovirology 6(1) , 49 (2009).
- Mehta SR , WertheimJO, DelportW et al. Using phylogeography to characterize the origins of the HIV-1 subtype F epidemic in Romania. Infect. Genet. Evol. 11(5) , 975–979 (2011).
- Véras NM , GrayRR, de Macedo Brígido LF, Rodrigues R, Salemi M. High-resolution phylogenetics and phylogeography of human immunodeficiency virus type 1 subtype C epidemic in South America. J. Gen. Virol.92(7) , 1698–1709 (2011).
- Véras NM , SantoroMM, GrayRR et al. Molecular epidemiology of HIV type 1 CRF02_AG in Cameroon and African patients living in Italy. AIDS Res. Hum. Retroviruses 27(11) , 1173–1182 (2011).
- Gao F , VidalN, LiY et al. Evidence of two distinct subsubtypes within the HIV-1 subtype A radiation. AIDS Res. Hum. Retroviruses 17(8) , 675–688 (2001).
- Meloni ST , KimB, SankaleJL et al. Distinct human immunodeficiency virus type 1 subtype A virus circulating in west Africa: sub-subtype A3. J. Virol. 78(22) , 12438–12445 (2004).
- Vidal N , MulangaC, BazepeoSE, LepiraF, DelaporteE, PeetersM. Identification and molecular characterization of subsubtype A4 in central Africa. AIDS Res. Hum. Retroviruses22(2) , 182–187 (2006).
- Triques K , BourgeoisA, SaragostiS et al. High diversity of HIV-1 subtype F strains in central Africa. Virology 259(1) , 99–109 (1999).
- Triques K , BourgeoisA, VidalN et al. Near-full-length genome sequencing of divergent African HIV type 1 subtype F viruses leads to the identification of a new HIV type 1 subtype designated K. AIDS Res. Hum. Retroviruses 16(2) , 139–151 (2000).
- Kanki PJ , HamelDJ, SankaléJL et al. Human immunodeficiency virus type 1 subtypes differ in disease progression. J. Infect. Dis. 179 , 68–73 (1999).
- Boivin MJ , RuelTD, BoalHE et al. HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children. AIDS 24(8) , 1163–1170 (2010).
- Benson DA , BoguskiMS, LipmanDJ et al. GenBank. Nucleic Acids Res. 27(1) , 12 (1999).
- Land S , CunninghamP, ZhouJ et al. TREAT Asia Quality Assessment Scheme (TAQAS) to standardize the outcome of HIV genotypic resistance testing in a group of Asian laboratories. J. Virol. Methods 159(2) , 185–193 (2009)
- de Oliveira T , ShaferRW, SeebregtsC. Public database for HIV drug resistance in southern Africa. Nature464(7289) , 673 (2010).
- Novitsky V , WesterCW, DeGruttolaV et al. The reverse transcriptase 67N 70R 215Y genotype is the predominant TAM pathway associated with virologic failure among HIV type 1C-infected adults treated with ZDV/ddI-containing HAART in southern Africa. AIDS Res. Hum. Retroviruses 23(7) , 868–878 (2007).
- Kuiken C , LeitnerT. HIV-1 subtyping. In: Computational and Evolutionary Analysis of HIV Molecular Sequences. Rodrigo AG, Learn GH Jr (Eds). Kluwer Academic Publishers, MA, USA, 27–53 (2002).
- Edgar RC . MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res.32(5) , 1792–1797 (2004).
- Hemelaar J , GouwsE, GhysPD, OsmanovS. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS20(16) , W13–W23 (2006).
- Korber B , MyersG. Signature pattern analysis: a method for assessing viral sequence relatedness. AIDS Res. Hum. Retroviruses8(9) , 1549–1560 (1992).
- Agresti A . Categorical Data Analysis (2nd Edition). Wiley-Interscience, NJ, USA (2002).
- Quinn GP , KeoughMJ. Experimental Design and Data Analysis for Biologists. Cambridge University Press, UK (2002).
- Benjamini Y , HochbergY. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Stat. Methodol.289–300 (1995).
- Shannon CE , WeaverW. A mathematical theory of communication. Bell Syst. Tech. J.27 , 379–423 (1948).
- Korber B . HIV signature and sequence variation analysis. In: Computational Analysis of HIV Molecular Sequences. Kluwer Academic Publishers, MA, USA 4 , 55–72 (2000).
- Rodrigues R , SchererLC, OliveiraCM et al. Low prevalence of primary antiretroviral resistance mutations and predominance of HIV-1 clade C at polymerase gene in newly diagnosed individuals from south Brazil. Virus Res. 116(1–2) , 201–207 (2006).
- Brígido LFM , FerreiraJLP, AlmeidaVC et al. Southern Brazil HIV type 1 C expansion into the State of São Paulo, Brazil. AIDS Res. Hum. Retroviruses 27(3) , 339–344 (2011).
- Castro-Nallar E , Pérez-LosadaM, BurtonGF, CrandallKA. The evolution of HIV: inferences using phylogenetics. Mol. Phylogenet. Evol.62(2) , 777–792 (2011).
- Tomiyama H , SakaguchiT, MiwaK et al. Identification of multiple HIV-1 CTL epitopes presented by HLA-B*5101 molecules. Hum. Immunol. 60(3) , 177–186 (1999).
- Kawashima Y , PfafferottK, FraterJ et al. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 458(7238) , 641–645 (2009).
- Kaslow RA , CarringtonM, AppleR et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV–1 infection. Nature Med. 2(4) , 405–411 (1996).
- Scorza Smeraldi R , FabioG, LazzarinA et al. HLA-associated susceptibility to AIDS: HLA B35 is a major risk factor for Italian HIV-infected intravenous drug addicts. Hum. Immunol. 22(2) , 73–79 (1988).
- Scorza Smeraldi R , LazzarinA, MoroniM, FabioG, EiseraNB, ZanussiC. HLA-associated susceptibility to acquired immunodeficiency syndrome in Italian patients with human-immunodeficiency-virus infection. Lancet328(8517) , 1187–1189 (1986).
- Just JJ . Genetic predisposition to HIV-1 infection and acquired immune deficiency virus syndrome: a review of the literature examining associations with HLA. Hum. Immunol.44(3) , 156–169 (1995).
- Yusim K , KesmirC, GaschenB et al. Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation. J. Virol. 76(17) , 8757–8768 (2002).
- Shafer RW , RheeSY, BennettDE. Consensus drug resistance mutations for epidemiological surveillance: basic principles and potential controversies. Antivir. Ther.13 , 59–68 (2008).
Website
- Los Alamos HIV databases. www.hiv.lanl.gov